Eye care practices bill two payer systems and carry three separate receivables, and the one blended revenue report almost every practice runs cannot say which of the three is failing.
Get a free revenue cycle assessmentOptometry revenue cycle management is the whole financial path of an eye care encounter, from deciding before the visit whether the vision plan or the medical carrier owns it, through coding, submission, posting and appeals, to the last dollar collected. Medical billing is one stage inside it: claim creation and submission.
Most specialties bill one payer per encounter. An eye care practice bills two systems that disagree about what happened in the chair, and a third for eyewear.
The vision plan pays a scheduled amount for a routine exam and materials, adjudicates in days, and treats the visit as a benefit draw. The medical carrier pays a fee schedule for eye disease, applies national edits, coverage articles and frequency limits, and takes weeks. Eyewear after cataract surgery is a prosthetic device benefit under Section 1861(s)(8), billable only by an enrolled DMEPOS supplier, to a different contractor, on a different claim.
Three ledgers, three clocks, one report. In our reviews, vision plan claims paid in a median of 11 days and medical carrier claims in 38 days, so a healthy blended average often sits on a medical ledger untouched for a month.
Claim size makes it worse. An eye care claim is small, so one denial rarely justifies a phone call and the write-off happens quietly at the line level. The money is in volume, and two points of net collection rate cost more than any denied procedure.
Then there is the optical. Retail cash, an insurance receivable and a prosthetic device benefit land in one system, and stock reports cannot say which is short. The claim-level mechanics underneath, the exam code families and the national edits, sit on our optometry billing services page.
Each of these is visible in numbers you already have.
Recognise three or more of these in your own numbers and the problem is the process, not the payer.
Get a free assessmentEye care divides by ownership, lane count, and whether an optical and a surgeon are attached.
The seven steps, as they run in an eye care practice, each with the point where it fails.
Two checks, not one: the vision plan for the routine and materials benefit, the medical carrier for everything else. The failure is booking type driving the check. Somebody scheduled for an annual exam turns up with flashes, and the claim still leaves on the plan verified at the desk. Demographics and the subscriber record are captured here too, and a transposed member ID rejects before adjudication.
Vision plan benefit authorization, referral rules under Medicare Advantage and Medicaid managed care, and prior authorization for advanced imaging and injectable drugs. The failure is an authorization pulled for a date that later moves. Panel effective dates belong here too, and under 42 CFR 424.515 enrollment is recertified every 5 years within 60 calendar days of notice, which is why credentialing sits inside the revenue cycle.
Refraction, premium lens options and materials outside the benefit are collected at the desk or not at all. Because 92015 is statutorily excluded rather than denied on medical necessity, that money is the patient's on the day of service. Collect it through patient billing at check-out or write it off later.
The exam families run 92002 to 92014 and 99202 to 99215, and testing, minor procedures, contact lens fitting and dispensed materials each originate in a different system, each needing an ICD-10 diagnosis that matches the order. The failure is a completed study that never becomes a charge.
A professional claim to the medical carrier, a benefit claim to the vision plan, a supplier claim to the DME MAC, each with its own edit set. The failure is one scrubber tuned for the medical claim and nothing checking the other two.
Posting is where underpayment is caught or lost. If the allowed amount is never compared with the contracted rate, the claim closes at the wrong number and the balance vanishes into an adjustment code.
Work denials by cause rather than by claim, in aging buckets, with a named owner per bucket. A queue nobody owns is how a small denial becomes a write-off. That is the whole of denials and AR recovery.
Organised by cause, not by code, modelled on a practice collecting about $1,200,000 across roughly 9,000 claims a year. Every row carries a Luxen finding.
| Leak point | Codes or rule | What goes wrong | Annual dollars at risk | Luxen audit finding |
|---|---|---|---|---|
| Denials that are never worked | Timely filing and appeal windows, plan by plan | Too small to justify a phone call, so it is adjusted and the reason never reaches a report | $32,000 | 19% of denied claims were never reworked or appealed |
| AR abandoned once it ages | Aging buckets past 90 and 120 days | The oldest medical claims stop moving while fast vision cash keeps the blended number normal | $22,000 | Claims aged past 180 days were recovered at 23% of dollar value |
| Silent contractual underpayment | Contracted fee schedule against the posted allowed amount | The payment posts, the balance closes, and nothing compares it with the contract | $24,000 | Underpayments against contracted rates appeared on 7.8% of paid claims |
| Non-covered balances billed, not collected | 92015, statutorily excluded | The charge leaves with the patient and becomes a statement competing with every other bill | $37,000 | Practices lost 3.1% of collections to patient balances written off before a second statement |
| Testing completed but never charged | 92083, 92133, 92134, 92250 | The study finishes in the imaging platform and no charge reaches the billing system | $11,000 | 9% of completed visual field and retinal imaging studies never produced a charge line |
| Enrollment and panel gaps | 42 CFR 424.515 revalidation, DMEPOS renewal under 42 CFR 424.57(g) | Claims go out under a number not yet effective, and V2020 eyewear cannot be filed at all | $31,000 | 1 in 5 optometry practices had a doctor seeing patients before the panel effective date |
We will tell you which of these leaks is open in your practice, free, in 30 minutes.
Book the reviewTwo columns, two sources. Typical for the first-pass denial rate comes from the CMS Marketplace Transparency in Coverage Public Use Files, 2024 plan year, issuer-level with no specialty segmentation. No federal series exists for the other five, so Typical there is the intake position of 47 optometry practices we reviewed. Every Target is Luxen client data.
| Metric | Definition | Typical | Target |
|---|---|---|---|
| Days in AR | Days from date of service to payment, per ledger | 38 days medical carrier, 11 days vision plan | 32 medical, 10 vision, reported apart monthly |
| Net collection rate | Collected as a share of allowed after contractual adjustments | 91% to 93% at intake | 97% or better within six months |
| Clean claim rate | Accepted on first submission with no correction | 88% to 92% at intake | 97% or better |
| First-pass denial rate | Denied on first adjudication | 19% of in-network claims denied, HealthCare.gov issuers, 2024 | 6% or lower |
| Cost to collect | Fully loaded revenue cycle cost as a share of collections | 7% to 9% at intake | 3% to 6%, all in |
| Point-of-service collection rate | Patient-owed and non-covered balances collected before the patient leaves | Under 50% at intake | 85% or better |
Typical values come from the named federal source in the table intro. Target values come from Luxen client data.
A billing service starts at the claim. The revenue cycle starts before the patient is seen, and in eye care that is where the largest recoverable dollars sit.
Four things, on four different systems. Vision plan benefit authorization, issued against the patient benefit before the exam or materials are supplied, which is standard at VSP, EyeMed, Davis Vision, Superior Vision and Spectera. Referral and plan rules under Medicare Advantage and Medicaid managed care, which vary by contract and often reject a clean claim on arrival. Prior authorization for advanced imaging and injectable drugs in OD and MD practices. And supplier-side authorization on the DMEPOS line for post-cataract eyewear.
Under the CMS Interoperability and Prior Authorization Final Rule, CMS-0057-F, impacted payers from January 1, 2026 must send standard prior authorization decisions within 7 calendar days and expedited decisions within 72 hours. They must give specific information about every prior authorization denial regardless of how the request was submitted, and must publish their own prior authorization metrics annually, including approval and denial percentages and average decision timeframes. Impacted payers include Medicare Advantage organizations, state Medicaid and CHIP agencies, their managed care plans, and qualified health plan issuers on the federally facilitated exchanges, although the 7 day standard timeframe excludes those issuers.
Most practices are not using that rule. A decision now has a deadline, a denial has to carry a reason, and the payer publishes its own numbers. We escalate on the date rather than on the denial, as part of eligibility and prior authorization.
Eye care has almost no concurrent review. The utilization decision arrives retrospectively, as a frequency or medical necessity denial on a test already performed, governed by coverage articles that bind one jurisdiction and by medically unlikely edits capping units per date. So the review has to happen in the practice, before submission, against the policy governing that contractor. Of the denial reasons reported by HealthCare.gov issuers for 2024, 9% were a lack of prior authorization or referral and 13% an excluded service.
The routine exam pays a scheduled amount and stops. Diagnostic testing decides whether the medical side is worth running, and it is the line most often lost between two pieces of software.
Extended visual field examination at 92083, scanning computerized ophthalmic diagnostic imaging of the optic nerve at 92133 and of the retina at 92134, fundus photography with interpretation and report at 92250, and extended ophthalmoscopy at 92201 and 92202. Each is ordered in the exam room, performed on a dedicated instrument and interpreted later: three systems, three timestamps, and a charge a human has to create in the fourth.
Not usually in the coding. In our audit, 9% of completed visual field and retinal imaging studies never produced a charge line, across 5,600 optometry claims audited. The study ran, the report was signed, and the practice management system was never told. No denial, no AR, and nothing in a standard report will surface it, because a charge that does not exist cannot age.
Repeat imaging on a stable glaucoma suspect is the most common medical necessity denial we see in eye care. Local coverage articles set the frequency a contractor will pay for and differ by jurisdiction, so a testing schedule that pays in Maine can deny elsewhere. Build the schedule against the governing policy, document the interpretation and report as a separate identifiable item, and reconcile weekly between the testing platforms and the charge file. Our medical coding team runs that reconciliation as a standing task rather than as an audit.
Pull the completed study list from each instrument each week and match it to charges by patient and date. Anything unmatched is either an uncharged study or an unsigned interpretation, and both are fixable inside the timely filing window. A practice running four testing platforms finds something every week for the first quarter. That is the difference between an annual audit, which tells you what you lost, and a weekly reconciliation, which stops you losing it.
Claim level findings come from the Luxen claim audit of 61,400 claims, January 2025 to June 2026, of which 5,600 were optometry claims. Practice level findings come from 47 optometry practices inside the Luxen billing reviews. We counted what was performed against what was charged, what was charged against what was paid, and how long each ledger took to clear.
Cite this work as The 2026 Luxen Optometry Revenue Cycle Audit.
A four-doctor practice, two locations, one optical, collecting about $1,300,000 a year, after a biller left and the replacement search ran long.
Reported by the practice administrator, a two-location optometry group, November 2025 to June 2026.
Same practice: $1,200,000 collected across about 9,000 claims, average $133 per claim, first-pass denial rate 14% at intake, about 3,600 billable diagnostic studies a year at an average $33 allowed, and about $180,000 collected directly from patients.
Recovered in year one: $88,500. The fee at 5% is $60,000, and the recovered dollars carry their own 5%, another $4,400. Net $24,100, before any change in AR.
Then the working capital. Practices that reviewed AR ageing monthly carried 12 fewer days in AR, and twelve days of $1,200,000 is $39,500 released once, as cash rather than revenue.
Want this arithmetic run on your own collections and denial rate?
Run my numbersLuxen charges 3% to 6% of collections. Eye care usually lands mid range, because the work covers three claim types rather than one.
The percentage covers coding, submission on all three claim types, scrubbing, posting and contract reconciliation, denials and appeals, patient statements, AR follow-up, and monthly reporting split by ledger. Month to month, 30 days notice, nothing to pay to start or to leave.
Same practice. In-house figures are fully loaded: salary, payroll taxes, benefits, cover during absence and the search when the seat empties.
| Line item | In-house | Luxen |
|---|---|---|
| Billing staff, fully loaded | One biller plus part-time front-end support, roughly $78,000 | Included |
| Coding capability | Bought in, or learned after the denial | Certified coders, included |
| Clearinghouse and scrubbing | $3,600 to $6,000 a year, tuned for the medical claim only | Included, all three claim types |
| Denial rework and appeals | First thing dropped when the schedule is full | Worked by root cause, every aging bucket |
| Contract reconciliation | Rarely performed at all | Every allowed amount checked against contract |
| Cover when the seat is empty | Open biller roles took a median of 67 days to fill | No single point of failure |
| Annual cost | About 7% to 9% of collections | 3% to 6% of collections |
Not the front desk. What moves out is the work that only happens when nothing else is urgent: denial root cause analysis, appeals, aged AR, underpayment detection and enrollment tracking. 34% of practice managers replaced a biller in the past two years, and the cost of that is the quarter of unworked AR either side of it.
A single-location, almost entirely vision plan practice whose long-tenured biller reports by ledger and works denials weekly should change nothing. Otherwise, compare medical billing companies on fee basis and on what they will show you.
People search for a national ranking. The only ranking that matters is against your own claim mix. Score any candidate out of 20, four points per criterion, and walk away below 14.
Two answers end the conversation: a refusal to show a client denial report, and a scrubber described as handling everything when you file three claim types.
The practice reading this already has someone doing the billing. The handover is built so nothing stops.
A BAA is signed before anyone touches a system, and we work inside the practice management system already in place, so there is no migration, no data export and no new login for the doctors. Current claims keep going out on the existing schedule while we start on the oldest medical carrier AR, which is where the recoverable cash sits and where the incumbent has stopped working. Two weeks from a signed BAA to claims being worked is normal. First recovered payments arrived a median of 17 days after work began. Your incumbent gets 30 days notice on your timetable, and there is no exit fee at our end. The first monthly report splits vision, medical and DMEPOS, which for most practices is the first time those numbers have been seen apart.
We work inside whatever is already installed, whether that is RevolutionEHR, Compulink Advantage, Eyefinity, Crystal Practice Management, Uprise, or Nextech and Epic in OD and MD groups. No migration, no data export, no new login for the doctors.
Automate in this order, because each step makes the next cheaper. First, dual eligibility at scheduling, which removes the largest single cause of rework. Second, the weekly match between testing platforms and the charge file, which is recovered revenue with no payer involved. Third, contracted rates loaded against posting, so underpayment is caught the day it arrives. Fourth, denial routing by reason code to a named owner. Predictive denial scoring comes fifth, because a model trained on a broken front end predicts your own mistakes back to you.
Pre-visit eligibility and benefit determination, authorization and referral, patient access and the non-covered balance, charge capture, coding and submission, payment posting with contract reconciliation, and denial management with AR follow-up. Each stage above carries its eye care failure mode. Stage three weighs more here than in most specialties, because a statutorily excluded charge such as 92015 belongs to the patient on the day of service or not at all.
No national list answers that usefully, because the right partner depends on your claim mix rather than company size. Score candidates on five things: whether vision, medical and DMEPOS AR are reported separately each month; whether eligibility and authorization run before the visit; whether they will show a live client denial report by root cause; whether your contracted rates are checked against every posted payment; and whether the fee basis is in writing. Missing denial reporting was the main reason 52% of switchers gave for leaving their last vendor.
The largest group is a coverage decision made before the visit: one plan verified at check-in while the chart documents a medical complaint. Frequency and medical necessity denials on repeat imaging at 92133, 92134 and 92250 come next, governed by coverage articles that bind only the contractor that issued them. Across HealthCare.gov issuers in the 2024 plan year, 9% of reported denial reasons were a lack of prior authorization or referral and 13% were an excluded service.
It is normally priced as a percentage of collections. Luxen charges 3% to 6%, set by claim mix, average claim value, number of payer contracts and whether the DMEPOS line is in scope, with nothing to pay to start or to leave. Fully loaded in-house cost for a practice collecting around $1,200,000 runs about 7% to 9% of collections once benefits, cover and turnover are counted.
Roughly two weeks pass between the signed BAA and claims being worked, because the work happens inside the practice management system already in place. First recovered payments land a median of 17 days after work begins. The denial rate moves inside the first 90 days, aged AR recovery runs across two quarters, and the median appeal turnaround is 34 days from filing to payer decision.
Medical billing is claim creation, submission and follow-up. Revenue cycle management is the whole path from the appointment being booked to the last dollar collected, adding the benefit decision before the visit, authorization, point-of-service collection, contract reconciliation at posting, and provider enrollment. In eye care that gap decides the outcome, because the two most expensive errors, choosing the wrong payer and never collecting a non-covered charge, both happen before a claim exists.
Checked against primary sources on 14 September 2026.
A coverage article binds one jurisdiction, so a testing frequency that pays in one state denies in the next. Practices in Arkansas answer to a different contractor, and we check the governing policy per client.
A free 30 minute review of your AR ageing and denial reasons. We tell you what is recoverable and what it would take. No deck, no commitment, no fee.
Book a free revenue cycle assessment%20(1).avif)
